Leidos (LDOS) is trading up at $127.64 (+1.26%) on NYSE/NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Industrials sector.
Current price targets from 2 firms average $139, ranging from $135 to $142 — 9% above the current $128. Each is tracked to its date and scored the same way a member's call is.
Targets published by research firms, extracted from the news, checked against independent reporting, and linked to their source. Where a firm did not state a horizon the target is tracked as 12 months, the industry convention; the rows where the firm set its own horizon are marked. Reported here as facts about what was published — not recommendations from Dalsna Finance, and no firm listed is affiliated with this site.
| FY2016Dec 2016 | FY2017Dec 2017 | FY2018Dec 2018 | FY2019Jan 2020 | FY2020Jan 2021 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Jan 2025 | FY2025Jan 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $7.04B | $10.2B | $10.2B | $11.1B | $12.3B | $13.7B | $14.4B | $15.4B | $16.7B | $17.2B |
| Growth (year over year) | +39.1% | +44.4% | +0.2% | +8.8% | +10.8% | +11.7% | +4.8% | +7.2% | +7.9% | +3.1% |
| Gross profit | $940.0M | $1.43B | $1.50B | $1.55B | $1.74B | $2.01B | $2.08B | $2.24B | $2.80B | $3.10B |
| Gross margin | 13.3% | 14.1% | 14.8% | 14.0% | 14.1% | 14.7% | 14.5% | 14.5% | 16.8% | 18.0% |
| Operating income | $417.0M | $559.0M | $749.0M | $912.0M | $998.0M | $1.15B | $1.09B | $621.0M | $1.83B | $2.11B |
| Operating margin | 5.9% | 5.5% | 7.3% | 8.2% | 8.1% | 8.4% | 7.6% | 4.0% | 11.0% | 12.3% |
| Net income | $244.0M | $366.0M | $581.0M | $667.0M | $628.0M | $753.0M | $685.0M | $199.0M | $1.25B | $1.45B |
| Net margin | 3.5% | 3.6% | 5.7% | 6.0% | 5.1% | 5.5% | 4.8% | 1.3% | 7.5% | 8.4% |
| EPS (diluted) | $2.35 | $2.38 | $3.80 | $4.60 | $4.36 | $5.27 | $4.96 | $1.44 | $9.22 | $11.14 |
| Balance sheet | ||||||||||
| Cash and equivalents | $376.0M | $390.0M | $327.0M | $668.0M | $524.0M | $727.0M | $516.0M | $641.0M | $849.0M | $1.11B |
| Total assets | $9.13B | $8.99B | $8.77B | $9.37B | $12.5B | $13.3B | $13.1B | $12.7B | $13.0B | $13.5B |
| Total liabilities | $5.99B | $5.61B | $5.46B | $5.95B | $8.64B | $8.92B | $8.72B | $8.44B | $8.55B | $8.53B |
| Long-term debt | $3.23B | $3.06B | $2.98B | $2.92B | $4.64B | $4.59B | $3.93B | $4.66B | $4.05B | $4.63B |
| Shareholders' equity | $3.13B | $3.37B | $3.31B | $3.41B | $3.86B | $4.29B | $4.30B | $4.20B | $4.41B | $4.92B |
| Cash flow | ||||||||||
| Operating cash flow | $449.0M | $526.0M | $768.0M | $992.0M | $1.33B | $1.03B | $992.0M | $1.19B | $1.44B | $1.75B |
| Capital expenditure | $29.0M | $81.0M | $73.0M | $121.0M | $183.0M | $104.0M | $129.0M | $207.0M | $149.0M | $125.0M |
| Free cash flow | $420.0M | $445.0M | $695.0M | $871.0M | $1.15B | $929.0M | $863.0M | $980.0M | $1.29B | $1.63B |
| Dividends paid | $993.0M | $0 | $0 | — | — | — | — | — | — | — |
| Share buybacks | $0 | $0 | $167.0M | $25.0M | $67.0M | $237.0M | $0 | $225.0M | $850.0M | $400.0M |
| Q3 FY24Sep 2024 | Q4 FY24†Jan 2025 | Q1 FY25Apr 2025 | Q2 FY25Jul 2025 | Q3 FY25Oct 2025 | Q4 FY25†Jan 2026 | Q1 FY26Apr 2026 | Q2 FY26Jul 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $4.19B | $4.37B | $4.25B | $4.25B | $4.47B | $4.21B | $4.40B | $4.56B |
| Growth (year over year) | +6.9% | +9.7% | +6.8% | +2.9% | +6.7% | −3.6% | +3.7% | +7.2% |
| Gross profit | $762.0M | $693.0M | $757.0M | $782.0M | $821.0M | $739.0M | $761.0M | $817.0M |
| Gross margin | 18.2% | 15.9% | 17.8% | 18.4% | 18.4% | 17.6% | 17.3% | 17.9% |
| Operating income | $516.0M | $421.0M | $530.0M | $571.0M | $535.0M | $473.0M | $508.0M | $514.0M |
| Operating margin | 12.3% | 9.6% | 12.5% | 13.4% | 12.0% | 11.2% | 11.5% | 11.3% |
| Net income | $364.0M | $284.0M | $363.0M | $391.0M | $367.0M | $327.0M | $328.0M | $354.0M |
| Net margin | 8.7% | 6.5% | 8.6% | 9.2% | 8.2% | 7.8% | 7.5% | 7.8% |
| EPS (diluted) | $2.68 | $2.10 | $2.77 | $3.01 | $2.82 | $2.54 | $2.56 | $2.81 |
| Balance sheet | ||||||||
| Cash and equivalents | $1.10B | $849.0M | $842.0M | $930.0M | $974.0M | $1.11B | $457.0M | $748.0M |
| Total assets | $13.3B | $13.0B | $13.2B | $13.5B | $13.5B | $13.5B | $15.4B | $15.6B |
| Total liabilities | $8.67B | $8.55B | $8.89B | $8.84B | $8.59B | $8.53B | $10.3B | $10.3B |
| Long-term debt | $4.08B | $4.05B | $5.01B | $4.99B | $4.63B | $4.63B | $6.01B | $6.01B |
| Shareholders' equity | $4.61B | $4.41B | $4.26B | $4.66B | $4.91B | $4.92B | $5.01B | $5.28B |
| Cash flow | ||||||||
| Operating cash flow | $647.0M | $294.0M | $58.0M | $486.0M | $711.0M | $495.0M | $301.0M | $793.0M |
| Capital expenditure | $23.0M | $86.0M | $22.0M | $29.0M | $31.0M | $43.0M | $31.0M | $32.0M |
| Free cash flow | $624.0M | $208.0M | $36.0M | $457.0M | $680.0M | $452.0M | $270.0M | $761.0M |
| Share buybacks | $200.0M | $400.0M | $0 | $0 | $100.0M | $300.0M | $200.0M | $66.0M |
From Leidos's 10-K, 10-KT and 10-Q filings with the SEC; its fiscal year ends in January. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
Leidos's latest reported figures next to the median of the other 81 S&P 500 Industrials companies and of the other 502 S&P 500 companies; each median is taken over the companies with a comparable figure (counts in the footnote). A median is the middle value, not an average, so one very large company does not move it.
| Measure | Leidos | Industrials (81 other S&P 500 companies) | S&P 500 (502 other companies) |
|---|---|---|---|
| Revenue growth, latest fiscal year | +3.1% | +4.6% | +7.0% |
| Net margin, latest fiscal year | 8.4% | 12.6% | 13.0% |
| Dividend per share, latest fiscal year | $1.63 | $2.67 | $2.40 |
| Share price change, 1 year | −33.8% | +7.0% | +5.9% |
Leidos: fiscal year ended January 2026, from its 10-K, 10-KT and 10-Q filings with the SEC. Medians computed October 20, 2026 from each company's latest annual filing (fiscal years ending between July 2025 and September 2026) and our price archive. Prices for every company, Leidos included, are the last regular-session prices of October 19, 2026; the 1-year change compares that price with each company's last close on or before October 20, 2025. Net margin and price change are our calculations from reported figures. Each median counts only the companies with a comparable figure (sector / S&P 500): revenue growth 79/496, net margin 79/496, dividend per share 63/349, 1-year price change 79/490; the reasons below can overlap. 12 are left out of the price figure because our archive holds no comparable close for them; dividend medians are among the 63 sector and 349 S&P 500 companies reporting a per-share dividend. The S&P 500 price figure is the middle company's change, not the index's return.
Leidos Holdings, Inc. is an American defense, aviation, information technology, and biomedical research company headquartered in Reston, Virginia, that provides scientific, engineering, systems integration, and technical services. Founded as Science Applications International Corporation (SAIC), Leidos merged with Lockheed Martin's IT sector, Information Systems & Global Solutions, in August 2016 to create the defense industry’s largest IT services provider. The Leidos-Lockheed Martin merger is one of the biggest transactions thus far in the consolidation of the defense sector. Leidos contracts extensively with the Department of Defense, the Department of Homeland Security, and the Intelligence Community, as well as other U.S. government agencies and select commercial markets.
JPMorgan downgrades Leidos stock rating on margin concerns
JPMorgan downgrades Leidos stock rating on margin concerns
Leidos names Stephen Vather as investor relations head
Leidos names Stephen Vather as investor relations head
Leidos wins $85m Air Force contract for aerospace design
Leidos wins $85m Air Force contract for aerospace design
Is Leidos Stock Underperforming the Dow?
Is Leidos Stock Underperforming the Dow?
Leidos at Jefferies Global Industrials Conference 2026: growth broadens
Leidos at Jefferies Global Industrials Conference 2026: growth broadens
TD Cowen reiterates Hold on Leidos stock amid contract concerns
TD Cowen reiterates Hold on Leidos stock amid contract concerns
Leidos wins $56M Navy contract for military health research
Leidos wins $56M Navy contract for military health research